or
forgot password
  • cancer clinical trials in chicago, IL

  • Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL
    Hematology-Oncology Associates of Illinois

    Trial Locations
    Hematology-Oncology Associates of Illinois
    Northwestern University
    Non-Hodgkin's Lymphoma
    A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    University of Chicago, Section of Hematology/Oncology MC2115
    Non-small Cell Lung Cancer
    Temsirolimus in Treating Patients With Recurrent Locally Advanced or Metastatic Breast Cancer
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Hematology and Oncology Associates

    Trial Locations
    Hematology and Oncology Associates
    Northwestern University
    University of Chicago Comprehensive Cancer Center
    Resurrection Healthcare
    University of Illinois
    Jesse Brown Veterans Affairs Medical Center
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Papillary Thyroid Cancer, Recurrent Thyroid Cancer, Stage III Follicular Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer, Thyroid Gland Medullary Carcinoma
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    University of Chicago Cancer Research Center
    Chicago, Illinois 60637
    Esophageal Cancer
    Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
    Children's Memorial Hospital - Chicago
    Chicago, Illinois 60614
    Brain and Central Nervous System Tumors
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Louis A. Weiss Memorial Hospital

    Trial Locations
    Louis A. Weiss Memorial Hospital
    Resurrection Medical Center
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Louis A. Weiss Memorial Hospital

    Trial Locations
    Louis A. Weiss Memorial Hospital
    Creticos Cancer Center at Advocate Illinois Masonic Medical Center
    Resurrection Medical Center
    Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    University of Chicago Comprehensive Cancer Center

    Trial Locations
    University of Chicago Comprehensive Cancer Center
    University of Illinois
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    University of Illinois
    Chicago, Illinois 60612
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
    Children's Memorial Hospital - Chicago

    Trial Locations
    Children's Memorial Hospital - Chicago
    University of Chicago Comer Children's Hospital
    Brain and Central Nervous System Tumors
    AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
    Northwestern University Feinberg School of Medicine
    Chicago, Illinois 60611
    Glioblastoma Multiforme
    Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Rush University Medical Center
    Chicago, Illinois 60612-3824
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    University of Chicago Comprehensive Cancer Center

    Trial Locations
    University of Chicago Comprehensive Cancer Center
    Childrens Memorial Hospital
    University of Illinois
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
    John H Stroger Jr Hospital of Cook County
    Chicago, Illinois 60612-3785
    Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
    Rush University Medical Center
    Chicago, Illinois 60612-3824
    Non-small Cell Lung Cancer
    Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    University of Chicago; Division of Infectious Diseases
    Mycoses, Candidiasis, Invasive, Candidemia
    Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Louis A. Weiss Memorial Hospital
    Prostate Cancer
    Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis, Unspecified Adult Solid Tumor, Protocol Specific
    Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma
    University of Chicago
    Chicago, Illinois 60637
    Mucosal Melanoma, Acral/Lentiginous Melanoma, Chronically Sun Damaged Melanomas
    Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
    NorthwesternUniv.Med.School/Robert H. Lurie Comp.Cancer Ctr Dept. of NorthwesterUMed
    Chicago, Illinois 60611
    Cutaneous T-Cell Lymphoma
    A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
    Rush University
    Chicago, Illinois 60612
    Peripheral T-cell Lymphoma
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University

    Trial Locations
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Hematology and Oncology Associates
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor